SkinHealth Systems Inc. (SKIN)

Import this data to Google Sheets with:

=jivedata("SKIN","financials")

Full statements spill as a table. For one cell: =jivedata("SKIN","Revenue") or =jivedata("SKIN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

SkinHealth Systems Inc.

SKIN • CIK 0001818093

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$523,025	$370,063	$232,673	$206,074
Accounts Receivable, after Allowance for Credit Loss, Current	$54,697	$27,643	$21,741	$17,640
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$14,226	$5,978	$2,538	$2,088
Inventory, Net	$91,321	$69,113	$48,012	$46,842
Operating Lease, Right-of-Use Asset	$12,120	$13,590	$11,570	$19,397
Income Taxes Receivable, Current	$332	$818	$1,696	$1,992
Finite-Lived Intangible Assets, Net	$62,123	$47,512	$35,763	$30,218
Prepaid Expense and Other Assets, Current	$28,877	$9,487	$5,395	$22,693
Goodwill	$125,818	$123,499	$126,621	$126,349
Assets, Current	$698,252	$477,124	$309,517	$295,241
Deferred Income Tax Assets, Net	$531	$3,894	$1,925	$2,350
Other Assets, Noncurrent	$16,043	$14,086	$11,869	$10,930
Assets	$929,113	$685,683	$499,803	$486,573
Operating Lease, Liability, Noncurrent	$9,319	$10,813	$9,238	$17,975
Deferred Income Tax Liabilities, Net	$702	$396	$393	$393
Convertible Debt, Noncurrent	$738,372	$552,198	$240,431	$242,120
Other Liabilities, Noncurrent	$2,767	$1,833	$2,410	$2,319
Liabilities	$869,723	$633,880	$438,747	$431,005
Convertible Debt, Current	—	—	$123,959	$103,089
Accounts Payable, Current	$44,768	$21,941	$15,631	$16,051
Employee-related Liabilities, Current	$22,028	$17,636	$24,947	$13,114
Operating Lease, Liability, Current	$4,598	$5,147	$5,128	$3,857
Accrued Income Taxes, Current	$2,759	$3,426	$1,226	$482
Accrued Liabilities, Current	$19,846	$20,002	$15,384	$31,605
Liabilities, Current	$115,008	$68,152	$186,275	$168,198
Common Stock, Value, Issued	$12	$12	$13	$13
Additional Paid in Capital	$541,281	$566,709	$579,961	$583,737
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-3,036	$-6,953	$-1,434	$-1,399
Retained Earnings (Accumulated Deficit)	$-478,867	$-507,965	$-517,484	$-526,783
Stockholders' Equity Attributable to Parent	$59,390	$51,803	$61,056	$55,568
Accounts Receivable, Allowance for Credit Loss, Current	$6,604	$9,597	$6,022	$3,652
Common Stock, Shares Authorized	320,000,000	320,000,000	320,000,000	320,000,000
Common Stock, Shares, Issued	122,899,002	124,924,185	127,520,823	130,104,671
Inventory, Raw Materials, Net of Reserves	$24,406	$26,019	$18,546	$19,361
Inventory, Finished Goods, Net of Reserves	$66,915	$43,094	$29,466	$27,481
Inventory Write-down	$18,272	$28,041	$7,219	$742
Standard and Extended Product Warranty Accrual	$6,000	$4,000	$1,000	$1,000
Restricted Cash	—	$2,000	$2,000	$2,000
Accrued Salaries, Current	$10,458	$10,708	$17,905	$8,330
Accrued Sales Commission, Current	$7,565	$4,784	$4,791	$3,207
Accrued Employee Benefits, Current	$4,005	$2,144	$2,251	$1,577
Sales and Excise Tax Payable, Current	$4,971	$5,244	$3,571	$3,273
Interest Payable, Current	$2,344	$1,743	$2,929	$2,862
Accrued Royalties, Current	$3,914	$1,897	$1,571	$1,490
Contract with Customer, Liability, Current	—	$2,375	$1,012	$1,165
Other Accrued Liabilities, Current	$8,617	$8,743	$6,301	$4,815
Accounts Receivable, Credit Loss Expense (Reversal)	$5,153	$5,134	$2,067	$651
Accounts Receivable, Allowance for Credit Loss, Writeoff	$1,478	$2,141	$5,642	$5,642

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-100,116	$-29,098	$-9,519	$-28,434
Net Cash Provided by (Used in) Operating Activities	$21,750	$16,134	$37,485	$21,960
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$-47,205	$-149,001	$-142,604	$-5,805
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$2,033	$-3,961	$5,214	$-121
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$523,025	$370,063	$232,673	$64,000
Share-based Payment Arrangement, Noncash Expense	$22,544	$26,696	$14,824	$11,014
Payments to Acquire Intangible Assets	$9,224	$6,038	$4,860	$4,503
Amortization of Intangible Assets	$20,907	$19,537	$16,988	$17,254
Payments to Acquire Property, Plant, and Equipment	$3,825	$756	$303	$817
Depreciation	$11,332	$9,940	$3,848	$2,373
Amortization of Other Deferred Charges	$2,436	$4,203	$4,513	$4,764
Net Cash Provided by (Used in) Investing Activities	$-31,507	$-6,794	$-5,163	$-5,320
Amortization of Debt Issuance Costs	—	$3,319	$3,636	$3,996
Inventory Write-down	$18,272	$28,041	$7,219	$5,483
Accounts Receivable, Credit Loss Expense (Reversal)	$5,153	$5,134	$2,067	$1,141
Fair Value Adjustment of Warrants	$-11,919	$-3,067	$-487	$-348
Gain (Loss) on Extinguishment of Debt	—	$33,411	$18,089	$19,108
Deferred Income Taxes and Tax Credits	—	$-3,748	$2,219	$951
Other Operating Activities, Cash Flow Statement	$5,988	$15,981	$-107	$7,297
Proceeds from Convertible Debt	$0	—	$237,601	$-701
Repayments of Convertible Debt	—	$156,082	$18,372	$20,161
Payment, Tax Withholding, Share-based Payment Arrangement	$3,234	$1,957	$1,572	$1,583
Payments for Repurchase of Common Stock	$30,155	$0	$0	$0
Payment for Contingent Consideration Liability, Financing Activities	$1,819	$0	$0	$0
Proceeds from (Payments for) Other Financing Activities	$0	$-302	$0	$0
Net Cash Provided by (Used in) Financing Activities	$-37,448	$-158,341	$-174,926	$-22,445
Interest Paid, Excluding Capitalized Interest, Operating Activities	$9,375	$8,014	$14,440	$14,440
Stock Issued During Period, Value, Acquisitions	$1,310	$0	$0	$0
Increase (Decrease) in Accounts Receivable	$-16,520	$-20,804	$-5,162	$-6,256
Increase (Decrease) in Inventories	$22,617	$10,500	$-15,792	$-7,172
Increase (Decrease) in Prepaid Expense and Other Assets	$3,285	$-15,479	$-3,423	$14,785
Increase (Decrease) in Accounts Payable and Accrued Liabilities	—	$-43,776	$-7,179	$5,647
Increase (Decrease) in Other Operating Assets and Liabilities, Net	$7,597	$9,400	$6,825	$6,802

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("SKIN","financials")

Full statements spill as a table. For one cell: =jivedata("SKIN","Revenue") or =jivedata("SKIN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.